Content Here
Corporate Strategies
MCS brings C-Suite and Board-level guidance to new heights that clarifies all aspects of your corporate strategy development and execution, ensuring direction and momentum as you grow, evolve or plan an exit.
Mergers & Acquisitions
MCS positions companies for successful M&A with capital introductions and negotiations at all stages for each transaction.
Capital Introductions and Value Based Diligence
We provide our clients with selective access to our exclusive MCS Investor Network of financing partners from commercial banks and private equity groups to family offices, venture capital groups, angel and high net-worth investors.
Corporate Restructuring and Market Readiness
If the timing of the M&A transaction is not quite right yet, MCS repositions companies for successful M&A via tried-and-true corporate restructuring and market readiness guidance.
Product Launch and Market Access
MCS’s executives have decades of marketing strategy and product launch experience in every sector in which we specialize.
Investor and Public Relations
Investor relations are at the core of obtaining support and attaining results; such an impact can propel a company’s profitability, growth, and market share, independent of the type of industry or the size of the enterprise.
Regulatory
We provide end-to-end regulatory affairs services that span the entire drug life cycle from early development through to submission and license approval to post-approval marketing maintenance. We support manufacturers, packagers, labelers, suppliers, distributors, importers, and warehouses.
Quality & Compliance
We provide GCP, GLP, and GMP consulting services for pharmaceuticals, natural health products, medical devices, cosmetics, and over-the-counter products.
Importing
The importation of regulated products into Canada requires prior approvals. We provide a clear path to product and establishment licenses while developing and maintaining your quality management system. License access includes drug products, OTC, natural health products (NHP), medical devices, active pharmaceutical ingredients (API), and cosmetics.

